genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Peregrine Pharmaceuticals
Cancer
Peregrine Pharmaceuticals Axing 20% of Workforce, 60 Jobs, in Restructuring
Industry News
MilliporeSigma Signs Biomanufacturing Deal with Avid Bioservices
Drug Discovery
Avid Expands for Avid Fans
Bioprocessing
CMOs Hold Their Ground in Troubled Times
News
Peregrine to Investigate Antiviral Applications of mAbs under $44M Deal with DoD
Insights
CROs Step Up Activities in Developing Countries
News
Peregrine Pharmaceuticals Inks $50M mAb Development Deal with Dios Therapeutics
News
Immunocytokine Agents Target of Peregrine and Biotecnol Partnership
Scroll Up
Scroll Up
